Font size:
Small
Medium
Large

ITRI Berlin Office

ITRI Berlin Office.ITRI Berlin Office.

ITRI’s Berlin office was inaugurated in 1996. It initiates and streamlines cooperation with European R&D and innovation stakeholders. Starting with the machinery industry as its major focus, its scope has expanded to application domains such as smart manufacturing, ambient-assisted living, green ICT, renewable energy, healthcare services, and other cross-disciplinary innovations. Our goal is to combine Taiwan’s ICT strength and commercialization speed with Europe’s innovation system and human-centered design approach to result in win-win collaborations. Hand in hand with Europe, we act as a bridge to facilitate research, development, and innovation (RDI) collaboration in tackling societal challenges while promoting economic growth in a smart, sustainable, and inclusive way.

Mission & Vision

Synergizing the respective strengths of the European and Taiwanese industry and innovation communities to achieve common goals.

Our Role

  • Representing ITRI in Europe
  • Suggesting strategic plans for the Taiwanese Ministry of Economic Affairs (MOEA) for its R&D engagement in Europe
  • Supporting the execution of MOEA’s industrial and institutional collaborative projects
  • Serving as a platform to bridge European and Taiwanese industry

Services

  • Assist Taiwanese companies and R&D institutions in joining European precompetitive research projects
  • Support development of bi- and multilateral commercialization projects
  • Consult on IP utilization in and with Taiwan
  • Facilitate contract research
ITRI President Dr. Edwin Liu visited overseas office in Berlin.ITRI President Dr. Edwin Liu visited overseas office in Berlin.
Under the witness of deputy Economics Ministers of Taiwan and Sweden , Dr. Fang-Chu Chen signed a MOU with AstraZeneca on behalf of ITRI’s Biomedical Technology and Device Research Laboratories in September 2019. Under the witness of deputy Economics Ministers of Taiwan and Sweden , Dr. Fang-Chu Chen signed a MOU with AstraZeneca on behalf of ITRI’s Biomedical Technology and Device Research Laboratories in September 2019.

Contact

  • Contact window: Mr. Ying-Wei Lin, ITRI European Deputy Representative
  • ITRI Berlin Office
    Hohenzollerndamm 187, 7. OG., 10713 Berlin, Germany
  • Tel: +49-30-8609-3615
  • Email: contact_germany@itri.org.tw
TOP